المؤلفون: Ünal Metin Tokat, Ashkan Adibi, Esranur Aydın, Şevval Nur Bilgiç, Eylül Özgü, Onur Tutar, Mutlu Demiray

المصدر: Frontiers in Oncology, Vol 14 (2025)

مصطلحات موضوعية: breast cancer, precision oncology, cancer genomics, HER2 antibody-drug conjugates (HER2 ADC), trastuzumab deruxtecan, neratinib, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2024.1484750/full; https://doaj.org/toc/2234-943X

URL الوصول: https://doaj.org/article/6af26a460ffe43a382c2101e7ed95639

المؤلفون: Jangsoon Lee, Kumiko Kida, Jiwon Koh, Huey Liu, Ganiraju C. Manyam, Young Jin Gi, Dileep R. Rampa, Asha S. Multani, Jing Wang, Gitanjali Jayachandran, Dae-Won Lee, James M. Reuben, Aysegul Sahin, Lei Huo, Debu Tripathy, Seock-Ah Im, Naoto T. Ueno

المصدر: Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-20 (2024)

مصطلحات موضوعية: HER2+ breast cancer, HER2 antibody–drug conjugates, DNA damage repair pathway, T-DXd, HER2-directed ADC resistance, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1756-9966

URL الوصول: https://doaj.org/article/96dec9fe852b4c2f9909c30d5560016b